Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

The use of contrast media

Mark O. Baerlocher, Murray Asch and Andy Myers
CMAJ April 20, 2010 182 (7) 697; DOI: https://doi.org/10.1503/cmaj.090118
Mark O. Baerlocher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murray Asch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andy Myers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

All contrast agents are not equal

The two main types of iodine-based contrast media are ionic and nonionic. The development of ionic contrast media in the 1920s and 1930s allowed radiologists to visualize vessels and organs on various imaging studies. However, these have some degree of toxicity, and the introduction of non-ionic media in the 1970s led to fewer adverse reactions. 1 Newer contrast media include low-osmolar ionic, iso-osmolar and gadolinium-based media. The last type is used in magnetic resonance imaging.

Adverse reactions are more common with ionic contrast media

Nonionic contrast media are well tolerated and have a better safety profile than ionic agents (Table 1). 2,3

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 1: Incidence of adverse reactions to contrast media administered intravascularly 2,3

A previous adverse reaction to intra-vascular contrast media increases the risk of a subsequent reaction

The risk of a subsequent adverse reaction is 17%–35% with ionic contrast media and 5% with nonionic media. 1

High-osmolar ionic contrast media should not be used intravascularly

High-osmolar ionic contrast media are no longer used intravascularly because of the increased risk of adverse reactions. Safer, low-osmolar ionic formulations are now available. Although higher costs limited the widespread use of nonionic agents in the past, the cost differential is now low. 4 There are only limited data available on the use of iso-osmolar contrast agents.

Avoid oral administration of ionic contrast media

If aspirated, ionic contrast media are much more likely than nonionic media to be associated with adverse reactions. Reactions in the lungs include bronchospasm, pulmonary edema, increased pulmonary vascular resistance and histamine release from lung mast cells and basophils. 5 Avoid using ionic agents in endoscopy of the upper gastrointestinal tract or when checking chest drains or assessing the position of nasogastric feeding tubes.

Footnotes

  • Previously published at www.cmaj.ca

    This article has been peer reviewed.

    Competing interests: None declared.

    For more information on the use of contrast media, see the American College of Radiology Manual on Contrast Media at www.acr.org/contrast-manual.

    “Five things to know about …” is a new series that presents key statements on topics of interest to physicians. For author instructions, go to cmaj.ca.

REFERENCES

  1. 1.↵
    Namasivayam S, Kalra MK, Torres WE, et al. Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol 2006;12:210–5.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Morcos SK, Thomsen HS. Adverse reactions to iodinated contrast media. Eur Radiol 2001;11: 1267–75.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Thomsen HS, Bush WH. Adverse effects of contrast media: incidence, prevention and management. Drug Saf 1998;19:313–24.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Thomas SM, Williams JE, Adam EJ. Intravascular contrast media: Can we justify the continued use of ionic contrast agents?Clin Radiol 1997;52:59–61.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Morcos SK. Effects of radiographic contrast media on the lung. Br J Radiol 2003;76:290–5.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 182 (7)
CMAJ
Vol. 182, Issue 7
20 Apr 2010
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The use of contrast media
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The use of contrast media
Mark O. Baerlocher, Murray Asch, Andy Myers
CMAJ Apr 2010, 182 (7) 697; DOI: 10.1503/cmaj.090118

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
The use of contrast media
Mark O. Baerlocher, Murray Asch, Andy Myers
CMAJ Apr 2010, 182 (7) 697; DOI: 10.1503/cmaj.090118
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • All contrast agents are not equal
    • Adverse reactions are more common with ionic contrast media
    • A previous adverse reaction to intra-vascular contrast media increases the risk of a subsequent reaction
    • High-osmolar ionic contrast media should not be used intravascularly
    • Avoid oral administration of ionic contrast media
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Duodenal duplication cyst in a 61-year-old man
  • A young woman with fever and polyserositis caused by familial Mediterranean fever
  • Screening for primary aldosteronism in primary care
Show more Practice

Similar Articles

Collections

  • Article Types
    • Five Things to Know About
  • Topics
    • Imaging

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire